Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JRK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RYK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FEM1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM13B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALMS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDLIM5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
FN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APBB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IQGAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PMP22 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLHDC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIF2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRSF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NACA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYH8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ESR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBE2D3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRRC2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM121 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on